From: Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar
Generation
No. of mice
No. of tumor-bearing mice1
Take rate(%)
survival time(d)
1
15
5
33
47.6 ± 1.8
2
10
50
42.2 ± 1.8
3
7
70
40.8 ± 1.2
4
100
38.0 ± 0.9
38.6 ± 1.0
6
37.8 ± 0.9